超声引导下甲状腺结节热消融的并发症及相关危险因素:9667例经验
该回顾性单中心研究分析了2018年1月至2023年3月接受超声引导下热消融(微波或射频消融)的9667例甲状腺结节患者,总体并发症发生率为4.43%,主要并发症发生率为1.94%(出血1.32%、声音嘶哑0.54%、症状性无菌性坏死0.08%),所有并发症均缓解;研究还识别了出血和声音嘶哑的独立危险因素。
要点
- 总体并发症发生率4.43%,主要并发症1.94%,包括出血1.32%、声音嘶哑0.54%。
- 出血的独立危险因素包括结节体积大、射频消融、富血供结节、良性结节、术前血压高、甲状腺功能亢进及消融功率高。
- 声音嘶哑的独立危险因素包括背侧结节和高消融功率。
核心结论
- 本研究提示超声引导下热消融是甲状腺结节的安全治疗方法,术前应考虑出血和声音嘶哑的相关危险因素,并针对不同情况患者考虑不同消融方式。
研究设计与样本
- 回顾性单中心研究,纳入2018年1月至2023年3月接受超声引导下热消融(微波或射频消融)的甲状腺结节患者9667例,其中微波消融4494例(46.49%),射频消融5173例(53.51%);在消融术中、术后即刻、术后1-3小时及术后1、3、6个月评估并发症,采用单因素和多因素分析识别声音嘶哑和出血并发症的危险因素。
临床应用与阅片要点
- 作者认为术前应考虑出血和声音嘶哑的危险因素,并对不同情况患者考虑不同消融方式;热消融可能是适合的甲状腺结节患者的安全治疗方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the safety of ultrasound-guided thermal ablation (UGTA) for thyroid nodules (TNs) by analysing complications and related risks.
MATERIALS AND METHODS: This retrospective, single-centre study reviewed patients who underwent UGTA (microwave or radiofrequency ablation) between January 2018 and March 2023. The incidence of complications was recorded and assessed during and immediately after ablation,1-3 h later, and at 1 month, 3 months, and 6 months. Univariate and multivariate analyses were performed to identify risk factors for hoarseness and haemorrhagic complications.
RESULTS: We reviewed 9667 cases in this study. Overall, 4494 (46.49%) cases underwent microwave ablation, while 5173 (53.51%) cases underwent radiofrequency ablation. The overall complication rate was 4.43%. The incidence of major complications was 1.94% (haemorrhage, 1.32%; hoarseness, 0.54%; and symptomatic aseptic necrosis, 0.08%). The incidence of minor complications was 2.45%. A large nodule volume, radiofrequency ablation, hyper-enhancing nodules, benign nodules, higher preoperative blood pressure, hyperthyroidism, and higher ablation power were independent risk factors for haemorrhage. Dorsal nodules and a higher ablation power were independent risk factors for hoarseness. All complications were resolved.
CONCLUSION: This study suggests that UGTA is a safe treatment for TNs. Several risk factors for haemorrhage and hoarseness should be considered before performing UGTA. Different ablation modalities should be considered for patients with different conditions.
CLINICAL RELEVANCE STATEMENT: Thermal ablation may be a safe treatment for eligible patients with TNs.
KEY POINTS: We analysed the complications and risk factors associated with UGTA in 9667 cases. The complication rate was 4.43%; 1.94% were major complications. Risk factors of haemorrhage and hoarseness should be considered. UGTA was a safe method for the treatment of TNs.
引用
- Liang X, Jiang B, Ji Y, et al. Complications of ultrasound-guided thermal ablation of thyroid nodules and associated risk factors: an experience from 9667 cases. Eur Radiol. 2024. PMID: 39174654. doi:10.1007/s00330-024-11023-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。